Myomo, Inc. (MYO) vs Xtant Medical Holdings, Inc. (XTNT)
Myomo, Inc. and Xtant Medical Holdings, Inc. are both Medical Devices companies. Myomo, Inc. is the larger, with a market value of $64.6M against $52.9M — 1.2× the size. Myomo, Inc. grew revenue faster over the last twelve months: 6.14% against −14.3%. Xtant Medical Holdings, Inc. has the higher net margin (−10.2% vs −33.5%) and the higher return on invested capital (−12.4% vs −167.9%). Across the 18 metrics below, Xtant Medical Holdings, Inc. leads on 13 and Myomo, Inc. on 5.
Valuation
Profitability
| Metric | MYO | XTNT | Medical Devices median |
|---|---|---|---|
| Gross margin | 68.35% | 59.39% | 56.01% |
| Operating margin | (27.05%) | (9.58%) | (15.03%) |
| Net margin | (33.53%) | (10.17%) | (20.40%) |
| Free cash flow margin | (21.01%) | (0.42%) | (7.24%) |
| Return on equity | (123.76%) | (25.16%) | (15.32%) |
| Return on assets | (39.20%) | (12.16%) | (19.72%) |
| Return on invested capital | (167.90%) | (12.43%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack